Planning predictable aligner treatments: five data-driven principles

The greatest challenge in aligner therapy is rarely getting the treatment started; it is finishing it efficiently. Unpredictability only rarely stems from software or material. More often it comes from clinical planning decisions: unsuitable case selection, biologically unrealistic movement goals, an imprecise attachment strategy, lack of staging control, poorly planned interproximal enamel reduction (IPR), compliance problems and patchy monitoring. The following guide summarises five principles that CLARIQUE's certified manufacturing partner has distilled from its clinical publications.

Principle 1: Case selection is the most important clinical decision

Predictability is highest when the planned movements stay within biological limits, the anchorage requirement is realistic, the periodontium is healthy and compliance is likely. Borderline cases are not off limits, but statistically they lead to multiple refinements, extended treatment duration and compromised outcomes. Practices that honestly segment their case acceptance win twice: clinically through more realistic goals, economically through predictable case costs.

Principle 2: Biomechanics applies digitally too

The planning software approves almost any movement; biology does not. Classic problem areas are uncontrolled tipping instead of bodily movement, excessive rotation of round teeth (canines, premolars), intrusion without adequate anchorage, and expansion beyond the limits of the alveolar process. Each of these movements looks effortless in the 3D setup; clinically, force transmission decides. A setup should therefore be read not as an animation but as a biomechanical blueprint.

Principle 3: Attachments are anchors, not decoration

Attachments are biomechanical functional elements. Too few mean loss of control on rotation- and extrusion-critical teeth; unnecessary attachments cost comfort and acceptance; incorrect geometry compromises the planned movement. The attachment strategy therefore belongs in the plan review: not accepted as a software suggestion, but actively checked against the planned movements.

Principle 4: Staging and force management matter more than the number of aligners

The number of trays is an outcome, not a target. What matters is how movements are sequenced: poor staging causes tracking loss, posterior open bites and unwanted tipping. These problems only surface in the second half of treatment and then force refinements. Progressive, controlled staging with realistic movement rates per step is the most effective lever for efficient finishing. One addition: digital monitoring tools systematically overestimate actual tooth movement; chairside clinical verification remains mandatory.

Principle 5: Refinements are not failure, too many are a warning sign

The literature cites average refinement rates of 40 to 60 %, with an industry average of around 2.5 refinement scans per case (industry estimate cited in the manufacturing partner's publications, as of 2026). A refinement is thus a normal part of many treatments. If correction phases accumulate, however, that is a signal of unrealistic planning goals, inadequate staging or non-compliance, and should be used as process feedback rather than dismissed as individual bad luck.

The underrated factor: compliance and expectation management

Only around 36 % of patients wear their trays fully according to protocol (study figure as cited in the manufacturing partner's publication, as of 2026). At the same time, a comparative study published in 2025 and cited there shows that aligners are rated significantly better than brackets on aesthetics (8.7 vs 5.4) and wearing comfort (8.2 vs 4.9), while overall satisfaction is statistically on a par (9.0 vs 8.8), provided expectations were set realistically. Furthermore: 17.2 % of aligner cases are converted to brackets during treatment. A substantial share of these conversions is avoidable through better case selection and honest counselling about wear times and treatment duration. Compliance risks cannot be planned away, but they can be priced in, for instance through more conservative staging for cases with visibly elevated risk.

Checklist before case approval

• Does the case fit your own complexity profile, or is it a borderline case with elevated refinement risk?
• Do all planned movements stay within biological limits (tipping, rotation, intrusion, expansion)?
• Is every attachment functionally justified, and is none missing on control-critical teeth?
• Is the IPR sequence defined by timing and extent?
• Is the anchorage requirement realistically represented?
• Is the staging progressive and force-controlled, rather than optimised for a minimal tray count?
• Has the patient's compliance risk been assessed and factored into the plan?

A final note on roles: digital setups, planning data and the manufacturing partner's clinical pre-check are tools. The diagnosis, the approval of every treatment plan and every therapeutic decision rest exclusively with the treating dentist; no planning system and no manufacturer takes over that responsibility.